Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases

Yi Zhang, Jun Tang, Zhiqiang Tian, Jennifer C. van Velkinburgh, Jianxun Song, Yuzhang Wu, Bing Ni

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Fibrosis is a consequence of chronic inflammation and the persistent accumulation of extracellular matrix, for which the cycle of tissue injury and repair becomes a predominant feature. Both the innate and adaptive immune systems play key roles in the progress of fibrosis. The recently identified subsets of innate lymphoid cells (ILCs), which are mainly localize to epithelial surfaces, have been characterized as regulators of chronic inflammation and tissue remodeling, representing a functional bridge between the innate and adaptive immunity. Moreover, recent research has implicated ILCs as potential contributing factors to several kinds of fibrosis diseases, such as hepatic fibrosis and pulmonary fibrosis. Here, we will summarize and discuss the key roles of ILCs and their related factors in fibrotic diseases and their potential for translation to the clinic.

Original languageEnglish (US)
Pages (from-to)399-414
Number of pages16
JournalInternational Reviews of Immunology
Volume35
Issue number5
DOIs
StatePublished - Sep 2 2016

Fingerprint

Fibrosis
Lymphocytes
Inflammation
Pulmonary Fibrosis
Adaptive Immunity
Innate Immunity
Extracellular Matrix
Immune System
Liver
Wounds and Injuries
Research

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Zhang, Y., Tang, J., Tian, Z., van Velkinburgh, J. C., Song, J., Wu, Y., & Ni, B. (2016). Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases. International Reviews of Immunology, 35(5), 399-414. https://doi.org/10.3109/08830185.2015.1068304
Zhang, Yi ; Tang, Jun ; Tian, Zhiqiang ; van Velkinburgh, Jennifer C. ; Song, Jianxun ; Wu, Yuzhang ; Ni, Bing. / Innate Lymphoid Cells : A Promising New Regulator in Fibrotic Diseases. In: International Reviews of Immunology. 2016 ; Vol. 35, No. 5. pp. 399-414.
@article{a6dc482679494923bb71f4f9886af4cc,
title = "Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases",
abstract = "Fibrosis is a consequence of chronic inflammation and the persistent accumulation of extracellular matrix, for which the cycle of tissue injury and repair becomes a predominant feature. Both the innate and adaptive immune systems play key roles in the progress of fibrosis. The recently identified subsets of innate lymphoid cells (ILCs), which are mainly localize to epithelial surfaces, have been characterized as regulators of chronic inflammation and tissue remodeling, representing a functional bridge between the innate and adaptive immunity. Moreover, recent research has implicated ILCs as potential contributing factors to several kinds of fibrosis diseases, such as hepatic fibrosis and pulmonary fibrosis. Here, we will summarize and discuss the key roles of ILCs and their related factors in fibrotic diseases and their potential for translation to the clinic.",
author = "Yi Zhang and Jun Tang and Zhiqiang Tian and {van Velkinburgh}, {Jennifer C.} and Jianxun Song and Yuzhang Wu and Bing Ni",
year = "2016",
month = "9",
day = "2",
doi = "10.3109/08830185.2015.1068304",
language = "English (US)",
volume = "35",
pages = "399--414",
journal = "International Reviews of Immunology",
issn = "0883-0185",
publisher = "Informa Healthcare",
number = "5",

}

Zhang, Y, Tang, J, Tian, Z, van Velkinburgh, JC, Song, J, Wu, Y & Ni, B 2016, 'Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases', International Reviews of Immunology, vol. 35, no. 5, pp. 399-414. https://doi.org/10.3109/08830185.2015.1068304

Innate Lymphoid Cells : A Promising New Regulator in Fibrotic Diseases. / Zhang, Yi; Tang, Jun; Tian, Zhiqiang; van Velkinburgh, Jennifer C.; Song, Jianxun; Wu, Yuzhang; Ni, Bing.

In: International Reviews of Immunology, Vol. 35, No. 5, 02.09.2016, p. 399-414.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Innate Lymphoid Cells

T2 - A Promising New Regulator in Fibrotic Diseases

AU - Zhang, Yi

AU - Tang, Jun

AU - Tian, Zhiqiang

AU - van Velkinburgh, Jennifer C.

AU - Song, Jianxun

AU - Wu, Yuzhang

AU - Ni, Bing

PY - 2016/9/2

Y1 - 2016/9/2

N2 - Fibrosis is a consequence of chronic inflammation and the persistent accumulation of extracellular matrix, for which the cycle of tissue injury and repair becomes a predominant feature. Both the innate and adaptive immune systems play key roles in the progress of fibrosis. The recently identified subsets of innate lymphoid cells (ILCs), which are mainly localize to epithelial surfaces, have been characterized as regulators of chronic inflammation and tissue remodeling, representing a functional bridge between the innate and adaptive immunity. Moreover, recent research has implicated ILCs as potential contributing factors to several kinds of fibrosis diseases, such as hepatic fibrosis and pulmonary fibrosis. Here, we will summarize and discuss the key roles of ILCs and their related factors in fibrotic diseases and their potential for translation to the clinic.

AB - Fibrosis is a consequence of chronic inflammation and the persistent accumulation of extracellular matrix, for which the cycle of tissue injury and repair becomes a predominant feature. Both the innate and adaptive immune systems play key roles in the progress of fibrosis. The recently identified subsets of innate lymphoid cells (ILCs), which are mainly localize to epithelial surfaces, have been characterized as regulators of chronic inflammation and tissue remodeling, representing a functional bridge between the innate and adaptive immunity. Moreover, recent research has implicated ILCs as potential contributing factors to several kinds of fibrosis diseases, such as hepatic fibrosis and pulmonary fibrosis. Here, we will summarize and discuss the key roles of ILCs and their related factors in fibrotic diseases and their potential for translation to the clinic.

UR - http://www.scopus.com/inward/record.url?scp=84939478290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939478290&partnerID=8YFLogxK

U2 - 10.3109/08830185.2015.1068304

DO - 10.3109/08830185.2015.1068304

M3 - Review article

C2 - 26222510

AN - SCOPUS:84939478290

VL - 35

SP - 399

EP - 414

JO - International Reviews of Immunology

JF - International Reviews of Immunology

SN - 0883-0185

IS - 5

ER -